Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (29)
Rwan Elsanhoury, Abdulaziz Alasmari, Prashanth Parupathi, Mouhannad Jumaa, Suliman Al-Fayoumi, Avinash Kumar, Raed Khashan, Sami Nazzal & Ahmed Abu Fayyad. (2023) AI & experimental-based discovery and preclinical IND-enabling studies of selective BMX inhibitors for development of cancer therapeutics. International Journal of Pharmaceutics 645, pages 123384.
Crossref
Crossref
Jonathon R. Green, Prathap Kumar S. Mahalingaiah, Sujatha M. Gopalakrishnan, Michael J. Liguori, Scott W. Mittelstadt, Eric A.G. Blomme & Terry R. Van Vleet. (2023) Off-target pharmacological activity at various kinases: Potential functional and pathological side effects. Journal of Pharmacological and Toxicological Methods 123, pages 107468.
Crossref
Crossref
Lin Wang, Zhengjie Zhang, Dongke Yu, Liuqing Yang, Ling Li, Yuxin He & Jianyou Shi. (2023) Recent research of BTK inhibitors: Methods of structural design, pharmacological activities, manmade derivatives and structure–activity relationship. Bioorganic Chemistry 138, pages 106577.
Crossref
Crossref
Tia C. L. Kohs, Sven R. Olson, Jiaqing Pang, Kelley R. Jordan, Tony J. Zheng, Aris Xie, James Hodovan, Matthew Muller, Carrie McArthur, Jennifer Johnson, Bárbara B. Sousa, Michael Wallisch, Paul Kievit, Joseph E. Aslan, João D. Seixas, Gonçalo J. L. Bernardes, Monica T. Hinds, Jonathan R. Lindner, Owen J. T. McCarty, Cristina Puy & Joseph J. Shatzel. (2022) Ibrutinib Inhibits BMX-Dependent Endothelial VCAM-1 Expression In Vitro and Pro-Atherosclerotic Endothelial Activation and Platelet Adhesion In Vivo. Cellular and Molecular Bioengineering 15:3, pages 231-243.
Crossref
Crossref
Julie Osborn, Reena Mourya, Unmesha Thanekar, Weizhe Su, Lin Fei, Pranavkumar Shivakumar & Jorge A. Bezerra. (2021) Serum Proteomics Uncovers Biomarkers of Clinical Portal Hypertension in Children With Biliary Atresia. Hepatology Communications 6:5, pages 995-1004.
Crossref
Crossref
Fei Yang, Meng Duan, Faxiang Zheng, Lei Yu, Yuan Wang, Guowei Wang, Jie Lin, Shuang Han, Da Gan, Zhuoxian Meng & Shankuan Zhu. (2021) Fas signaling in adipocytes promotes low-grade inflammation and lung metastasis of colorectal cancer through interaction with Bmx. Cancer Letters 522, pages 93-104.
Crossref
Crossref
Garth E. Ringheim, Matthew Wampole & Kinsi Oberoi. (2021) Bruton’s Tyrosine Kinase (BTK) Inhibitors and Autoimmune Diseases: Making Sense of BTK Inhibitor Specificity Profiles and Recent Clinical Trial Successes and Failures. Frontiers in Immunology 12.
Crossref
Crossref
Xiu-Juan Liu, Xu-Liu, Xiao-Jing Pang, Xin -Ying Yuan, Guang-Xi Yu, Yin-Ru Li, Yong-Feng Guan, Yan-Bing Zhang, Jian Song, Qiu-Rong Zhang & Sai-Yang Zhang. (2021) Progress in the development of small molecular inhibitors of the Bruton’s tyrosine kinase (BTK) as a promising cancer therapy. Bioorganic & Medicinal Chemistry 47, pages 116358.
Crossref
Crossref
M. Arroyo, R. Larrosa, J. Gómez-Maldonado, M. Á. Cobo, M. G. Claros & R. Bautista. (2020) Expression-based, consistent biomarkers for prognosis and diagnosis in lung cancer. Clinical and Translational Oncology 22:10, pages 1867-1874.
Crossref
Crossref
Wei Zhang, Ping Zhou, Xiao Jiang, Zhe Fan, Xingxin Xu & Fei Wang. (2020)
Negative Regulation of Tec Kinase Alleviates LPS-Induced Acute Kidney Injury in Mice via theTLR4/NF-
κ
B Signaling Pathway
. BioMed Research International 2020, pages 1-15.
Crossref
Crossref
Kai Li, Wen-ting Pan, Yan-bin Ma, Xiao-long Xu, Yang Gao, Yan-qi He, Lei Wei & Jing-wei Zhang. (2019) BMX activates Wnt/β-catenin signaling pathway to promote cell proliferation and migration in breast cancer. Breast Cancer 27:3, pages 363-371.
Crossref
Crossref
Stephanie Jordaens, Leah Cooksey, Laurie Freire Boullosa, Viggo Van Tendeloo, Evelien Smits, Ken I. Mills, Kim H. Orchard & Barbara-ann Guinn. (2020) New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia. Cancer Immunology, Immunotherapy 69:5, pages 867-877.
Crossref
Crossref
Zhao LiMingzhu YinHaifeng ZhangWeiming NiRichard W. PierceHuanjiao Jenny ZhouWang Min. (2020) BMX Represses Thrombin-PAR1–Mediated Endothelial Permeability and Vascular Leakage During Early Sepsis. Circulation Research 126:4, pages 471-485.
Crossref
Crossref
Shih-Hsin Liang, Chang-Fang Chiu & Li-Yuan Bai. (2019) Ibrutinib-Associated Reversible Cardiomyopathy. Journal of Oncology Practice 15:12, pages 671-673.
Crossref
Crossref
Xiao-Feng Xu, Feng Gao, Jian-Jiang Wang, Cong Long, Xing Chen, Lan Tao, Liu Yang, Li Ding & Yong Ji. (2019) BMX-ARHGAP fusion protein maintains the tumorigenicity of gastric cancer stem cells by activating the JAK/STAT3 signaling pathway. Cancer Cell International 19:1.
Crossref
Crossref
Renata Ariza Marques Rossetti, Noely Paula Cristina Lorenzi, Kaori Yokochi, Maria Beatriz Sartor de Faria Rosa, Luciana Benevides, Paulo Francisco Ramos Margarido, Edmund Chada Baracat, Jesus Paula Carvalho, Luisa Lina Villa & Ana Paula Lepique. (2018) B lymphocytes can be activated to act as antigen presenting cells to promote anti-tumor responses. PLOS ONE 13:7, pages e0199034.
Crossref
Crossref
C. T. Watson, A. T. Cohain, R. S. Griffin, Y. Chun, A. Grishin, H. Hacyznska, G. E. Hoffman, N. D. Beckmann, H. Shah, P. Dawson, A. Henning, R. Wood, A. W. Burks, S. M. Jones, D. Y. M. Leung, S. Sicherer, H. A. Sampson, A. J. Sharp, E. E. Schadt & S. Bunyavanich. (2017) Integrative transcriptomic analysis reveals key drivers of acute peanut allergic reactions. Nature Communications 8:1.
Crossref
Crossref
Linhong He, Da Li, Chufeng Zhang, Peng Bai & Lijuan Chen. (2017) Discovery of (R)-5-(benzo[d][1,3]dioxol-5-yl)-7-((1-(vinylsulfonyl)pyrrolidin-2-yl)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (B6) as a potent Bmx inhibitor for the treatment of NSCLC. Bioorganic & Medicinal Chemistry Letters 27:17, pages 4171-4175.
Crossref
Crossref
Yuanyuan Li, Nan Cui, Peng-Sheng Zheng & Wen-Ting Yang. (2017) BMX/Etk promotes cell proliferation and tumorigenicity of cervical cancer cells through PI3K/AKT/mTOR and STAT3 pathways. Oncotarget 8:30, pages 49238-49252.
Crossref
Crossref
J. Molina-Cerrillo, T. Alonso-Gordoa, P. Gajate & E. Grande. (2017) Bruton?s tyrosine kinase (BTK) as a promising target in solid tumors. Cancer Treatment Reviews 58, pages 41-50.
Crossref
Crossref
Timothy D. Owens & Yan Lou. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
76
103
.
Elisa Calabria, Emilia Maria Cristina Mazza, Kenneth Allen Dyar, Silvia Pogliaghi, Paolo Bruseghini, Carlo Morandi, Gian Luca Salvagno, Matteo Gelati, Gian Cesare Guidi, Silvio Bicciato, Stefano Schiaffino, Federico Schena & Carlo Capelli. (2016) Aging: a portrait from gene expression profile in blood cells. Aging 8:8, pages 1802-1821.
Crossref
Crossref
Ogunleye Foluso, Alexander Glick, Michael Stender & Ishmael Jaiyesimi. (2016) Ibrutinib as a Bruton Kinase Inhibitor in the Management of Chronic Lymphocytic Leukemia: A New Agent With Great Promise. Clinical Lymphoma Myeloma and Leukemia 16:2, pages 63-69.
Crossref
Crossref
Wendy B. Young, James Barbosa, Peter Blomgren, Meire C. Bremer, James J. Crawford, Donna Dambach, Charles Eigenbrot, Steve Gallion, Adam R. Johnson, Jeffrey E. Kropf, Seung H. Lee, Lichuan Liu, Joseph W. Lubach, Jen Macaluso, Pat Maciejewski, Scott A. Mitchell, Daniel F. Ortwine, Julie Di Paolo, Karin Reif, Heleen Scheerens, Aaron Schmitt, Xiaojing Wang, Harvey Wong, Jin-Ming Xiong, Jianjun Xu, Christine Yu, Zhongdong Zhao & Kevin S. Currie. (2016) Discovery of highly potent and selective Bruton’s tyrosine kinase inhibitors: Pyridazinone analogs with improved metabolic stability. Bioorganic & Medicinal Chemistry Letters 26:2, pages 575-579.
Crossref
Crossref
A. Kancharla, M. Maoz, M. Jaber, D. Agranovich, T. Peretz, S. Grisaru-Granovsky, B. Uziely & R. Bar-Shavit. (2015) PH motifs in PAR1&2 endow breast cancer growth. Nature Communications 6:1.
Crossref
Crossref
A. Berglöf, A. Hamasy, S. Meinke, M. Palma, A. Krstic, R. Månsson, E. Kimby, A. Österborg & C. I. E. Smith. (2015) Targets for Ibrutinib Beyond B Cell Malignancies. Scandinavian Journal of Immunology 82:3, pages 208-217.
Crossref
Crossref
Xiaofeng Xu, Lifang Xu, Feng Gao, Jianjiang Wang, Jinsong Ye, Mingxian Zhou, Yunling Zhu & Lan Tao. (2014) Identification of a novel gene fusion (BMX-ARHGAP) in gastric cardia adenocarcinoma. Diagnostic Pathology 9:1.
Crossref
Crossref
Rudi W. Hendriks, Saravanan Yuvaraj & Laurens P. Kil. (2014) Targeting Bruton's tyrosine kinase in B cell malignancies. Nature Reviews Cancer 14:4, pages 219-232.
Crossref
Crossref
Danielle S. Potter, Paul Kelly, Olive Denneny, Veronique Juvin, Len R. Stephens, Caroline Dive & Christopher J. Morrow. (2014) BMX Acts Downstream of PI3K to Promote Colorectal Cancer Cell Survival and Pathway Inhibition Sensitizes to the BH3 Mimetic ABT-737. Neoplasia 16:2, pages 147-W16.
Crossref
Crossref